Article Information
PubMed
Print ISSN
Online ISSN
History
- Received April 28, 2005
- Accepted September 12, 2005
- Published online November 17, 2005.
Article Versions
- Earlier version (September 12, 2005 - 11:28).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Robert P. Picone,
- Atmaram D. Khanolkar,
- Wei Xu1,
- Lionel A. Ayotte,
- Ganesh A. Thakur1,
- Dow P. Hurst,
- Mary E. Abood,
- Patricia H. Reggio,
- Donna J. Fournier and
- Alexandros Makriyannis1
- Center for Drug Discovery (R.P.P., A.D.K., W.X., L.A.A., G.A.T., D.J.F., A.M.), Departments of Pharmaceutical Sciences (R.P.P., A.D.K., W.X., L.A.A., G.A.T., D.J.F., A.M.) and Molecular & Cell Biology (A.M.), University of Connecticut, Storrs, Connecticut; Department of Chemistry & Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina (D.P.H., P.H.R.); and Forbes Norris Amyotrophic Lateral Sclerosis/Muscular Dystrophy Association Research Center, California Pacific Medical Center, San Francisco, California (M.E.A.)
- Address correspondence to:
Alexandros Makriyannis, Center for Drug Discovery, Northeastern University, Boston, MA 02115. E-mail: a.makriyannis{at}neu.edu
Statistics from Altmetric.com
Article usage
In this issue
(-)-7′-Isothiocyanato-11-hydroxy-1′,1′-dimethylheptylhexahydrocannabinol (AM841), a High-Affinity Electrophilic Ligand, Interacts Covalently with a Cysteine in Helix Six and Activates the CB1 Cannabinoid Receptor
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement